The Atherectomy Devices market offers opportunities in treating coronary and peripheral artery diseases, particularly in developed countries. Growth is driven by minimally-invasive techniques ...

The United States Atherectomy Devices Market is expected to expand from US$ 316.05 Million in 2024 to US$ 627.59 Million by 2033. The growth signifies an impressive Compound Annual Growth Rate (CAGR) ...

DUBLIN--(BUSINESS WIRE)--The "Atherectomy Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been ...

New York, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Spain Atherectomy Devices Market Outlook to 2025 - Coronary Atherectomy Devices and Lower Extremity ...

REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne ...

REDWOOD CITY, CA / ACCESSWIRE / November 4, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...

Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l53xb3/global) has announced the addition of the "Atherectomy and ...

(MENAFN- GlobeNewsWire - Nasdaq) Growing demand in major states like California, New York, and New Jersey, supported by robust healthcare networks and reimbursement policies, is set to propel market ...